1-6 of 6
sars-cov-2
Close
Sort by
Journal Articles

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Clinical Trials & Observations
Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2794–2798.
https://doi.org/10.1182/bloodadvances.2021004957
Published: 2021
Journal Articles

A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2

Clinical Trials & Observations
Anne Louise Tølbøll Sørensen, Magalie Rolland, Jacob Hartmann, Zitta Barrella Harboe, Casper Roed, Tomas Ø. Jensen, Lilian Kolte, Daniel El Fassi, Jens Hillingsø, Aneta Radziwon-Balicka, Robert Sebastian Soyka, Klaus Hansen, Nikolai Kirkby, Jens P. Goetze, Mikkel Gybel-Brask, Eva Birgitte Leinøe, Anne-Mette Hvas, Peter Kampmann, Jakob Stensballe
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2569–2574.
https://doi.org/10.1182/bloodadvances.2021004904
Published: 2021
Journal Articles

The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A

Shang-Chuen Wu, Connie M. Arthur, Jianmei Wang, Hans Verkerke, Cassandra D. Josephson, Daniel Kalman, John D. Roback, Richard D. Cummings, Sean R. Stowell
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1305–1309.
https://doi.org/10.1182/bloodadvances.2020003259
Published: 2021
Includes: Supplemental data
Journal Articles

Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19

Chaja F. Jacobs, Eric Eldering, Arnon P. Kater
Journal: Blood Advances
Blood Adv (2021) 5 (3): 913–925.
https://doi.org/10.1182/bloodadvances.2020003768
Published: 2021
Includes: Supplemental data
Journal Articles

Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia

Clinical Trials & Observations
Lia Phillips, Jovana Pavisic, Dominder Kaur, N. Valerio Dorrello, Larisa Broglie, Nobuko Hijiya
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4358–4361.
https://doi.org/10.1182/bloodadvances.2020002745
Published: 2020
Journal Articles

COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease

Clinical Trials & Observations
Zahidee Rodriguez, Andi L. Shane, Hans Verkerke, Christopher Lough, Matthew G. Zimmerman, Mehul Suthar, Jens Wrammert, Heather MacDonald, Michael Wolf, Shanelle Clarke, John D. Roback, Connie M. Arthur, Sean R. Stowell, Cassandra D. Josephson
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4278–4281.
https://doi.org/10.1182/bloodadvances.2020002507
Published: 2020